#BioRxiv

Emma J Chory

chorye

It's a crazy time to be a scientist, but I feel fortunate and excited to be able to share the first bit of work from my postdoc... introducing PRANCE!"A high-throughput

Amy Harmon

amy_harmon

I wrote this because I'm fascinated by the emerging immune v not-immune-to-#COVID19 social divide. But many readers are expressing skepticism about the premise, that people who recover from infection with

Dr Gaetan Burgio, MD, PhD.

GaetanBurgio

I have seen few headlines on the repurposing of Ivermectin, a old FDA approved anti-parasitic drug, against #COVID19 infection. The claim is low dose of ivermectin kills #SARSCoV2 in cells.

Dr. Angela Rasmussen

angie_rasmussen

Big news today about another vaccine candidate. Take home messages:-It's safe-It's immunogenic (neutralizing antibodies and antigen-specific T cells)-It's a good size (n=1077 patients, 543 of whom got the vaccine vs

Daniel Mucida 🌹💉

danmucida

Tomasz Ahrends and coworkers report that "Enteric pathogens induce tissue tolerance and prevent neuronal loss from subsequent infections". A visual inspired by politics with a graphical anstract at the end.https://www.biorxiv.org/

Jonathan Pritchard

jkpritch

Our latest: "GWAS of three molecular traits highlights core genes and pathways alongside a highly polygenic background": https://www.biorxiv.org/content/10.1101/2020.04.20.051631v1 We use urate, IGF-1, and testosterone as model molecular tr

Renée van Amerongen

wntlab

New pre-print! A novel Axin2 knock-in mouse model for visualization and lineage tracing of WNT/CTNNB1 responsive cellsShared 1st authors @AnoeskaMoosdijk & Yorick van de Grift, with critical contributions by @Saskia_deMan

Sean Froudist-Walsh

seanfw

1) Three years ago I saw a fascinating talk by Nicola Palomero-Gallagher about the patterns of receptors across the brain. I spoke to her and the great Prof. Karl Zilles

Tim Travis

TimTravis2

I've been cataloging key takeaways regarding this pandemic that I've learned as a non-expert interested in following the data, which leads to different conclusions than narrative. My hope is to

Dr Gaetan Burgio, MD, PhD.

GaetanBurgio

This is a result that many hoped. Today the @NEJM published a small cohort study on the compassionate use of Remdesivir for severe #COVID19 patients in ICU under mechanical ventilation

Vinod Scaria

vinodscaria

B.1.617 is the nameFind more information on the lineage at https://cov-lineages.org/lineages/lineage_B.1.617.html This lineage is defined by 15 genetic variants including 6 Spike protein variants.Two variants of these 6 (E484Q and

Stats for bios

StatsForBios

For the past 4 years I've mostly worked on disaggregation regression. As this work is mostly published or in preprint, and because I doubt I'll be working much more on

Max Bertolero

max_bertolero

Our new work: “Racial and ethnic imbalance in neuroscience reference lists and intersections with gender”. We analyze the race and gender of citing and cited papers in neuroscience over the

Adam Kucharski

AdamJKucharski

How much could variation in social contacts and susceptibility influence the size of an outbreak (and hence notions of herd immunity)? Well, it depends on a few things... 1/ It's

Simon Roux

simroux_virus

It's Friday evening, I've my red wine, and we just got a new pre-print out, which means it's thread time \o/ Disclaimer: this thread doesn't contain any Covid-19 https://www.biorxiv.org/content/10.1101/2020.04.01.020958v1 @jgi

Jesse “Malthus was British” Matchey

JesseMatchey

Epstein co-founds Clinton Global InitiativeEpstein flies w/Clinton w/interests in HIV(like his site claims he’s interested in)Alain Merieux-Wuhan labClintons sign w/BioMerérieux on HIVBioMerérieux appoints WEF YGL Moderna CEO Stéphane